Researchers Validate Precision Medicine Approach Using New Whole Exome Sequencing Test

Weill Cornell Newsroom

Much of precision medicine and cancer care focuses on targeting the genomes of specific tumors or metastases. At Weill Cornell Medical College, a research team has now shown that a more global look at the body using next-generation sequencing can offer new insights — and targets — in patients with advanced, treatment-resistant disease. READ MORE